Genomenoninc
National Account Director, Business Development — RWE/Pharma (Remote US)
Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long di
National Account Director, Business Development — RWE/Pharma (Remote US)
Marketing Director, Clinical Diagnostics — Genomics (Remote)
Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long di
Marketing Director, Clinical Diagnostics — Genomics (Remote)
Manager, Genetic Product Quality (Fully Remote) — Variant Interpretation
Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long di
Manager, Genetic Product Quality (Fully Remote) — Variant Interpretation
General Interest in Genomenon for B&H: Share your resume and we'll keep it on file!
Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long di
General Interest in Genomenon for B&H: Share your resume and we'll keep it on file!
General Interest in Genomenon: Share your resume and we'll keep it on file!
Our Company Genomenon is an AI-driven genetic intelligence company on a mission to save and improve lives by making biomedical information actionable. Rare diseases and cancer affect more than 30 million people in the U.S. alone and hundreds of millions globally, yet most patients still face long di